Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
LHCSX vs HRTS
Shared holdings
17
LHCSX covered by HRTS
39.00%
HRTS covered by LHCSX
39.00%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
LHCSX (April 30, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 8.73% | |
| ASTRAZENECA PLC | 4.64% | |
| GILEAD SCIENCES INC | 4.17% | |
| JOHNSON&JOHNSON | 3.13% | |
| NEKTAR THERAPEUTICS | 3.11% | |
| NATERA INC | 2.86% | |
| TARSUS PHARMACEUTICALS INC | 2.78% | |
| GUARDANT HEALTH INC | 2.58% | |
| ARGENX SE | 2.51% | |
| Novartis AG (Registered) | 2.42% | |
| CVS HEALTH CORP | 2.33% | |
| MADRIGAL PHARMACEUTICALS INC | 2.18% | |
| INTUITIVE SURGICAL INC | 2.17% | |
| COGENT BIOSCIENCES INC | 2.15% | |
| GALDERMA GROUP A | 2.07% | |
| UNITEDHEALTH GRP | 2.06% | |
| CELCUITY INC | 1.97% | |
| BRIDGEBIO PHARMA INC | 1.95% | |
| CENCORA INC | 1.95% | |
| Ascendis Pharma A/S | 1.93% | |
| Abivax SA SPONSORED ADS | 1.83% | |
| EDWARDS LIFESCIENCES CORP | 1.79% | |
| FIXED INC CLEARING CORP.REPO | 1.75% | |
| MIRUM PHARMACEUTICALS INC | 1.72% | |
| UCB SA | 1.71% | |
| MONEY MARKET FUND | 1.69% | |
| DIANTHUS THERAPEUTICS INC | 1.67% | |
| UNITED THERAPEUTICS CORP DEL | 1.61% | |
| VERTEX PHARMACEUTICALS INC | 1.60% | |
| THERMO FISHER SCIENTIFIC INC | 1.45% | |
| REVOLUTION MEDICINES INC | 1.33% | |
| TEVA PHARMACEUTICAL IND ADR | 1.25% | |
| ADAPTIVE BIOTECHNOLOGIES CORP | 1.15% | |
| PTC THERAPEUTICS INC | 1.10% | |
| INSMED INC | 1.04% | |
| MINERALYS THERAPEUTICS INC | 1.03% | |
| OTSUKA HOLDINGS | 1.02% | |
| CG ONCOLOGY INC | 0.98% | |
| BEONE MEDICINE-H | 0.93% | |
| RHYTHM PHARMACEUTICALS INC | 0.92% | |
| GLAUKOS CORP | 0.91% | |
| ARROWHEAD PHARMACEUTICALS INC | 0.85% | |
| 10X GENOMICS INC | 0.85% | |
| HEARTFLOW INC | 0.85% | |
| ENCOMPASS HEALTH CORP | 0.82% | |
| GENEDX HOLDINGS CORP-A | 0.79% | |
| TRANSMEDICS GROUP INC | 0.79% | |
| DBV TECHNOLOGIES SA SPON ADR | 0.75% | |
| STRYKER CORP | 0.71% | |
| PROTAGONIST THERAPEUTICS INC | 0.69% |
HRTS (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 10.02% | |
| Roche Holding AG | 5.47% | |
| JOHNSON&JOHNSON | 4.86% | |
| ASTRAZENECA PLC | 4.82% | |
| MERCK & CO | 4.24% | |
| THERMO FISHER SCIENTIFIC INC | 3.90% | |
| UNITEDHEALTH GRP | 3.85% | |
| GILEAD SCIENCES INC | 3.62% | |
| Novartis AG (Registered) | 3.62% | |
| ABBOTT LABS | 3.37% | |
| VERTEX PHARMACEUTICALS INC | 3.21% | |
| ABBVIE INC | 2.96% | |
| DANAHER CORP | 2.92% | |
| BOSTON SCIENTIFIC CORP | 2.47% | |
| MEDTRONIC PLC | 2.37% | |
| BRIDGEBIO PHARMA INC | 2.23% | |
| REVOLUTION MEDICINES INC | 2.22% | |
| BRISTOL-MYERS SQUIBB CO | 2.17% | |
| MCKESSON CORP | 2.16% | |
| NOVO NORDISK-B | 2.15% | |
| AMGEN INC | 2.10% | |
| CHUGAI PHARMA CO | 2.06% | |
| REGENERON PHARMACEUTICALS INC | 2.02% | |
| EDWARDS LIFESCIENCES CORP | 1.86% | |
| TEVA PHARMACEUTICAL IND ADR | 1.62% | |
| CYTOKINETICS INC | 1.48% | |
| INTUITIVE SURGICAL INC | 1.47% | |
| MASIMO CORP | 1.36% | |
| DEXCOM INC | 1.29% | |
| MADRIGAL PHARMACEUTICALS INC | 1.21% | |
| INSMED INC | 1.19% | |
| ALNYLAM PHARMACEUTICALS INC | 1.19% | |
| INSULET CORP | 1.04% | |
| ARROWHEAD PHARMACEUTICALS INC | 1.03% | |
| VIKING THERAPEUTICS INC | 0.85% | |
| IONIS PHARMACEUTICALS INC | 0.83% | |
| SCHOLAR ROCK HOLDING CORP | 0.78% | |
| Ascendis Pharma A/S | 0.75% | |
| CRINETICS PHARMACEUTICALS INC | 0.64% | |
| FIRST AM-TR OB-X | 0.59% | |
| NEUROCRINE BIOSCIENCES INC | 0.57% | |
| ZEALAND PHARMA A | 0.56% | |
| GUBRA A/S | 0.51% | |
| INTELLIA THERAPEUTICS INC | 0.35% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.